Florida Senate - 2023                                     SB 612
       By Senator Yarborough
       4-00814-23                                             2023612__
    1                        A bill to be entitled                      
    2         An act relating to the prevention of blood clots;
    3         providing a short title; requiring the Agency for
    4         Health Care Administration, in conjunction with the
    5         Department of Health, to establish a blood clot and
    6         pulmonary embolism prevention policy workgroup;
    7         providing for membership, meetings, and duties of the
    8         workgroup; requiring the agency to submit a certain
    9         report to the Governor and the Legislature by a
   10         specified date; requiring the agency to submit a final
   11         report on the workgroup’s findings and recommendations
   12         by a specified date; providing for expiration of the
   13         workgroup; providing an effective date.
   15  Be It Enacted by the Legislature of the State of Florida:
   17         Section 1. This act may be cited as the “Emily Adkins Blood
   18  Clot Prevention Act.”
   19         Section 2. (1)The Agency for Health Care Administration,
   20  in conjunction with the Department of Health, shall establish a
   21  blood clot and pulmonary embolism prevention policy workgroup.
   22         (2)(a)The workgroup shall be composed of the following
   23  members:
   24         1.Four members representing state-licensed health care
   25  facilities, appointed by the Secretary of Health Care
   26  Administration.
   27         2.Four members representing state-licensed health care
   28  providers, appointed by the State Surgeon General. The Surgeon
   29  General shall select one of his or her appointees to serve as
   30  chair of the workgroup.
   31         3.Five members representing patients who have experienced
   32  blood clots, family members of patients who have died from blood
   33  clots, advocates for blood clot and pulmonary embolism
   34  prevention policies, health care associations, and other
   35  interested parties or associations, appointed by the Governor.
   36         4.Two members appointed by the President of the Senate.
   37         5.Two members appointed by the Speaker of the House of
   38  Representatives.
   39         (b)Members of the workgroup shall serve at their own
   40  expense and are not entitled to receive compensation or
   41  reimbursement for per diem or travel expenses.
   42         (c)The workgroup shall meet at the call of the chair and
   43  may conduct its meetings through teleconference or other
   44  electronic means.
   45         (d)The chair may create subcommittees to help with
   46  gathering research, scheduling speakers on relevant subjects,
   47  and drafting workgroup reports and policy recommendations.
   48         (3)The workgroup shall do all of the following, at a
   49  minimum:
   50         (a)Identify the aggregate number of people who experience
   51  blood clots and pulmonary embolisms each year in this state.
   52         (b)Identify how data is collected in this state regarding
   53  blood clots, pulmonary embolisms, and adverse health outcomes
   54  associated with these conditions.
   55         (c)Identify how blood clots and pulmonary embolisms impact
   56  the lives of residents in this state.
   57         (d)Identify the best practices and standards of care for
   58  blood clot surveillance, detection, and treatment.
   59         (e)Identify emerging treatments, therapies, and research
   60  relating to blood clots and pulmonary embolisms.
   61         (f)Develop a risk surveillance system to help health care
   62  providers identify patients who may be at higher risk for blood
   63  clots or pulmonary embolisms.
   64         (g)Develop policy recommendations to help improve patient
   65  awareness of blood clot risks.
   66         (h)Develop policy recommendations to help health care
   67  facilities, including, but not limited to, hospitals, ambulatory
   68  surgical centers, nursing homes, assisted living facilities, and
   69  residential treatment facilities, improve surveillance and
   70  detection of patients who may be at a higher risk for blood
   71  clots or pulmonary embolisms.
   72         (i)Develop recommended guidelines for the standard of care
   73  for patients at risk for blood clots or pulmonary embolisms.
   74         (j)Develop recommended literature relating to increased
   75  risks of blood clots which health care facilities and health
   76  care providers can provide to patients and their families.
   77         (4)By January 31, 2024, the Agency for Health Care
   78  Administration shall submit a report to the Governor, the
   79  President of the Senate, and the Speaker of the House of
   80  Representatives which provides an update on the workgroup’s
   81  activities, findings, and recommendations. The agency shall
   82  submit a final report on all of the workgroup’s findings and
   83  recommendations by January 31, 2025.
   84         (5)This section expires February 1, 2025.
   85         Section 3. This act shall take effect upon becoming a law.